HIGHLIGHTS
- who: Harri A. Ju00e4rvelu00e4inen et al. from the Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland have published the research: Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1, in the Journal: (JOURNAL) of 20/02/2023
- what: This study explored CEND-1`s pharmacokinetic (PK) properties pre-clinically and clinically and assessed CEND-1 distribution selectivity and duration of action in pre-clinical models. This study assessed the CEND-1 PK profile pre-clinically, as well as clinically patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.